| 000 | 01583 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517134032.0 | ||
| 264 | 0 | _c20170630 | |
| 008 | 201706s 0 0 chi d | ||
| 022 | _a0254-6450 | ||
| 024 | 7 |
_a10.3760/cma.j.issn.0254-6450.2017.01.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, L G | |
| 245 | 0 | 0 |
_a[Epidemiological characteristics of HBeAg reversion in chronic hepatitis B patients with HBeAg seroconversion in Jiangsu province, 2012-2014]. _h[electronic resource] |
| 260 |
_bZhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi _cJan 2017 |
||
| 300 |
_a43-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntiviral Agents |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSeroconversion |
| 700 | 1 | _aTian, H | |
| 700 | 1 | _aJiang, J | |
| 700 | 1 | _aSong, C | |
| 700 | 1 | _aZou, Y | |
| 700 | 1 | _aXu, J F | |
| 700 | 1 | _aLiu, H J | |
| 700 | 1 | _aPeng, H | |
| 700 | 1 | _aHu, Z B | |
| 700 | 1 | _aZhu, F C | |
| 700 | 1 | _aShen, H B | |
| 700 | 1 | _aZhai, X J | |
| 773 | 0 |
_tZhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi _gvol. 38 _gno. 1 _gp. 43-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3760/cma.j.issn.0254-6450.2017.01.008 _zAvailable from publisher's website |
| 999 |
_c26796900 _d26796900 |
||